These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6799299)

  • 21. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-oestrogen action in experimental breast cancer.
    Jordan VC; Naylor KE; Dix CJ; Prestwich G
    Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma.
    Boccardo F; Cerruti G; De Menech R; Valenti G; Zanardi S
    Oncology; 1987; 44(4):248-52. PubMed ID: 3112670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y; Takai Y; Sugamata N; Morishita Y
    Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxidase content in cell subpopulations of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Brightwell J; Tseng MT
    Cancer Res; 1982 Nov; 42(11):4562-6. PubMed ID: 6812949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL; Mangel WF; Katzenellenbogen BS
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of (4-14C)estradiol by 7,12-dimethylbenz(a) anthracene-induced mammary tumor peroxidase.
    Jellinck PH; Smith G; Cleveland S
    Steroids; 1975 Sep; 26(3):329-37. PubMed ID: 812211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of uterine steroid receptor levels and peroxidase activity during the puerperium of the nonlactating rat.
    Keeping HS; Lyttle CR
    Biol Reprod; 1982 Nov; 27(4):1011-22. PubMed ID: 7171662
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat.
    Asselin J; Labrie F
    J Steroid Biochem; 1978 Nov; 9(11):1079-82. PubMed ID: 106188
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of tamoxifen in laboratory animals.
    Jordan VC; Allen KE; Dix CJ
    Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative antioestrogen action in experimental breast cancer.
    Jordan VC
    Adv Exp Med Biol; 1981; 138():165-78. PubMed ID: 6805259
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of new drugs for endocrine tumour chemotherapy.
    von Angerer E
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
    Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of 1 alpha,25-dihydroxyvitamin D3 on the development and steroid hormone receptor contents of DMBA-induced rat mammary tumors.
    Noguchi S; Tahara H; Miyauchi K; Koyama H
    Oncology; 1989; 46(4):273-6. PubMed ID: 2500626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of high dietary fat on the total DNA and receptor contents in rats with 7,12-dimethylbenz[A]anthracene-induced mammary carcinoma].
    Noguchi M; Kumaki T; Taniya T; Koyasaki N; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1603-7. PubMed ID: 2124652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Waseda N; Kato Y; Matsushita N; Imura H
    Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
    Jordan VC
    Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.